Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0136bb206024de847a5974fecd28e2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3951c01f77506012990588f738a7dcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eeb7b0abd24674ffae86da3276a79b6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
filingDate |
2008-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9a2a7a8c6f5791b0b88c3e5a0102c38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65de3eacd29dbd2af8fb05faa6ff0a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9e4e475add0b6c54712c9974d6d195d |
publicationDate |
2009-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009039023-A2 |
titleOfInvention |
Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast |
abstract |
The present invention provides a method for differentiating in a subject the presence of ductal carcinoma in situ (DCIS) of the breast, benign breast fibroadenoma and non-cancerous breast tissue. The method consists in measuring the concentration of at least one protein biomarker selected from a group of forty-nine proteins differentially expressed in the saliva of people with DCIS or benign fibroadenoma or in individuals who are not affected. of a cancer. The test data obtained is compared to a reference group. On the basis of the comparison, the presence of ductal carcinoma in situ of the breast or of a benign breast fibroadenoma is determined in the subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2576816-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105891513-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105891518-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3384939-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3671213-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011133770-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2576816-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012123419-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011100472-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013116343-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9624547-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020128546-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013526869-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011133770-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9410188-B2 |
priorityDate |
2007-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |